After Option Exercise. After Option exercise, Biogen Idec will be solely responsible for the costs and expenses related to the Development, Manufacture and Commercialization of Products.
Appears in 2 contracts
Sources: Neurology Drug Discovery and Development Collaboration, Option and License Agreement (Isis Pharmaceuticals Inc), DMPK Research, Development, Option and License Agreement (Isis Pharmaceuticals Inc)
After Option Exercise. After Except as otherwise provided in Section 1.4.1(b), after Option exercise, Biogen Idec will be solely responsible for the costs and expenses related to the Development, Manufacture and Commercialization of Products.
Appears in 1 contract
Sources: Development, Option and License Agreement (Isis Pharmaceuticals Inc)
After Option Exercise. After Option exercise, Biogen Idec will be solely responsible for the costs and expenses related to the Development, Manufacture and Commercialization of Collaboration Products, including any work performed by Isis at Biogen Idec’s request, and all supply chain planning and decision-making.
Appears in 1 contract